Common Contracts

Immunome, Inc. [●] Shares Common Stock ($0.0001 par value) Underwriting Agreement

Underwriting Agreement • September 9th, 2020 • Immunome Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  September 9th, 2020
• Company
  Immunome Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Immunome, Inc., a corporation organized under the laws of Delaware (the “Issuer”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom Ladenburg Thalmann & Co. Inc. and Chardan Capital Markets, LLC are acting as representatives (the “Representatives”), [●] shares of common stock, $0.0001 par value per share (“Common Stock”) of the Issuer (said shares to be issued and sold by the Issuer being hereinafter called the “Underwritten Securities”). The Issuer also proposes to grant to the Underwriters an option to purchase up to [●] additional shares of Common Stock to cover over-allotments, if any (the “Option Securities;” the Option Securities, together with the Underwritten Securities, hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representative as used herein shall mean you, as Underwriter, and the terms Representatives and Underwriters shal

Eyenovia, Inc. 4,388,490 Shares Common Stock ($0.0001 par value) Underwriting Agreement

Underwriting Agreement • July 15th, 2019 • Eyenovia, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  July 15th, 2019
• Company
  Eyenovia, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Eyenovia, Inc., a corporation organized under the laws of Delaware (the “Issuer”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom Oppenheimer & Co. Inc. is acting as representative (the “Representative”), 4,388,490 shares of common stock, $0.0001 par value per share (“Common Stock”) of the Issuer (said shares to be issued and sold by the Issuer being hereinafter called the “Underwritten Securities”). The Issuer also proposes to grant to the Underwriters an option to purchase up to 658,273 additional shares of Common Stock to cover over-allotments, if any (the “Option Securities;” the Option Securities, together with the Underwritten Securities, hereinafter called the “Securities”). The offering and sale of the Securities contemplated by this Agreement is referred to herein as the “Offering.”

Eyenovia, Inc. 2,730,000 Shares Common Stock ($0.0001 par value) Underwriting Agreement

Underwriting Agreement • January 29th, 2018 • Eyenovia, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  January 29th, 2018
• Company
  Eyenovia, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Eyenovia, Inc., a corporation organized under the laws of Delaware (the “Issuer”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom Ladenburg Thalmann & Co. Inc. and Roth Capital Partners, LLC are acting as representatives (the “Representatives”), 2,730,000 shares of common stock, $0.0001 par value per share (“Common Stock”) of the Issuer (said shares to be issued and sold by the Issuer being hereinafter called the “Underwritten Securities”). The Issuer also proposes to grant to the Underwriters an option to purchase up to 409,500 additional shares of Common Stock to cover over-allotments, if any (the “Option Securities;” the Option Securities, together with the Underwritten Securities, hereinafter called the “Securities”). The offering and sale of the Securities contemplated by this Agreement is referred to herein as the “Offering.”